ESTRO 2025 - Abstract Book

S4235

RTT - Education, training, advanced practice and role developments

ESTRO 2025

RTT was identified as playing an active role in the screening, recruitment and consent processes. The RTT is a key communicator in the multidisciplinary team acting as an advocate and key contact for the patient on a trial. Table 2. Recruitment numbers for 2021- 2023 onto clinical trials.

CT Retention rate has remained high at 97%. RTTs play a crucial role in patient education, understanding, and support of patients throughout the clinical trial process. Conclusion: Effective screening and recruitment strategies are essential for successful radiotherapy CT management. RTTs are integral to the CT team, contributing to patient education, support, and protocol adherence. Future efforts will involve expanding the clinical trial portfolio to lung, site specific oligometastatic, head and neck, brain, and breast cancer CT.

Keywords: radiotherapy clinical trials, portfolio, research

2208

Digital Poster From Bottleneck to breakthrough: Enhancing Inpatient Radiation Therapy Throughput with an Advanced Practice Radiation Therapist (APRT) clodagh A starrs, Samantha Skubish, Maria Dimopoulos, Danielle McDonagh Radiation Oncology, Mount sinai hospital, New York, USA

Purpose/Objective: This study assessed the impact of an Advanced Practice Radiation Therapist (APRT) intervention on inpatient radiation therapy throughput, focusing on two metrics: (1) the proportion of patients scheduled for simulation but